离群值
贝叶斯概率
先验概率
计算机科学
稳健性(进化)
原始数据
贝叶斯分层建模
统计
数学
贝叶斯推理
人工智能
数据挖掘
生物化学
化学
基因
作者
Thomas Røraas,Sverre Sandberg,Aasne K. Aarsand,Bård Støve
出处
期刊:Clinical Chemistry
[American Association for Clinical Chemistry]
日期:2019-07-01
卷期号:65 (8): 995-1005
被引量:24
标识
DOI:10.1373/clinchem.2018.300145
摘要
Abstract BACKGROUND Biological variation (BV) data have many applications for diagnosing and monitoring disease. The standard statistical approaches for estimating BV are sensitive to “noisy data” and assume homogeneity of within-participant CV. Prior knowledge about BV is mostly ignored. The aims of this study were to develop Bayesian models to calculate BV that (a) are robust to “noisy data,” (b) allow heterogeneity in the within-participant CVs, and (c) take advantage of prior knowledge. METHOD We explored Bayesian models with different degrees of robustness using adaptive Student t distributions instead of the normal distributions and when the possibility of heterogeneity of the within-participant CV was allowed. Results were compared to more standard approaches using chloride and triglyceride data from the European Biological Variation Study. RESULTS Using the most robust Bayesian approach on a raw data set gave results comparable to a standard approach with outlier assessments and removal. The posterior distribution of the fitted model gives access to credible intervals for all parameters that can be used to assess reliability. Reliable and relevant priors proved valuable for prediction. CONCLUSIONS The recommended Bayesian approach gives a clear picture of the degree of heterogeneity, and the ability to crudely estimate personal within-participant CVs can be used to explore relevant subgroups. Because BV experiments are expensive and time-consuming, prior knowledge and estimates should be considered of high value and applied accordingly. By including reliable prior knowledge, precise estimates are possible even with small data sets.
科研通智能强力驱动
Strongly Powered by AbleSci AI